Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Patient Enrollment

Recent news which mentions Patient Enrollment

Axsome Therapeutics Commences Late-Stage Migraine Study
Tickers AXSM
Tags General AXSM Biotech
From Benzinga
Stoke Therapeutics Commences Initial-Stage Optic Nerve Disorder Study
Tickers STOK
Tags Biotech General Health Care
From Benzinga
Annovis Shares Gain As Late-Stage Parkinson's Disease Study Takes-off
Tickers ANVS
Tags Health Care Movers & Shakers Market News
From Benzinga
Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off
Tickers CUE
Tags Movers & Shakers Health Care Market News
From Benzinga
BridgeBio Shares Fall As Initial-Stage Rare Metabolic Disorder Study Kicks-off
Tickers BBIO
Tags BBIO Small Cap Benzinga
From Benzinga
Palisade Bio Shares Drop Following Commencement Of Late-Stage Return Of Bowel Study
Tickers PALI
Tags Biotech Markets PALI
From Benzinga
Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
Tickers ANIX
Tags Penny Stocks Patient Enrollment Health Care
From Benzinga
Virios Therapeutics Commences Mid-Stage Long-COVID Study
Tickers VIRI
Tags Biotech General Market News
From Benzinga
Avalo Therapeutics' Shares Climb Following Patient Dosing in Immunodeficiency Disorder Study
Tickers AVTX
Tags Benzinga AVTX General
From Benzinga
Kymera Therapeutics Commences Initial-Stage Oncology Trials
Tickers KYMR
Tags KYMR Benzinga Small Cap
From Benzinga
Apellis Begins Paitent Dosing In Late-Stage Study Of Rare Kidney Disease Candidate
Tickers APLS
Tags Health Care Market News Patient Enrollment
From Benzinga
Moderna Commences Late-stage Study of Flu Vaccine Candidate
Tickers MRNA
Tags Patient Enrollment Benzinga Market News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.